HMG

REC PPT-HMG // REV 2026-10-04 // assessment changes are logged, never silent

Menotropins — an established fertility medicine.

What it is

Human menopausal gonadotropin, containing both FSH and LH activity.

Stimulates follicular development and gonadal function in fertility treatment.

Does it work?

A long-established prescription fertility medicine used under specialist supervision. Not a wellness compound.

Each marketing claim, tagged by what the evidence actually supports.

Established fertility medicine under specialist care	supported
Useful as a general wellness compound	overreach

Quoted from published reference material. These are not Peptuity recommendations.

Vial75 IU

Diluent0.5 ml

Listed dose75 IU

Units / 1 ml50

Live counts from Europe PMC and ClinicalTrials.gov.

Publications 3,854

Randomised trials 210

Clinical trials 217

Registered studies 184

3,854 publications indexed, including 210 randomised controlled trials. 184 interventional studies registered. This is a well-tested compound.

SRC // EUROPE PMC + CTGOV // "human menopausal gonadotropin" // FETCHED 2026-10-04 // 3,854 RECORDS

Regulatory status

Formal, dated regulatory actions.

WADA — Prohibited List 2026

Prohibited for male athletes — WADA S2 (gonadotropins)

What is HMG used for clinically?

Fertility treatment — it supplies FSH and LH activity to stimulate follicular development and gonadal function, under specialist supervision.

How does it differ from HCG?

HCG mimics LH only; HMG carries both FSH and LH activity. They occupy different steps in fertility protocols.

Why does it appear in peptide catalogues?

Channel overlap, not evidence logic. It is an established hospital-grade medicine that grey-market catalogues list alongside research compounds.

Approved gonadotropin. The weight-loss ‘HCG diet’ is separately discredited.

Key reproductive-axis regulator with real academic research behind it.